The median values of other tumor markers (Ferritin, A19-9, AFP, CEA, B2M) for the PanNEN patients with bone metastases and those in the non-bone metastatic group were also not significantly different (p > 0.05) (Table 2). This evidence concerns the gene AFP and neoplasm.